Trials / Recruiting
RecruitingNCT06445322
Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH)
Prescreening Study to Identify Potential Participants With ABCA4-related Retinopathy for ACDN-01 Clinical Trials
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (estimated)
- Sponsor
- Ascidian Therapeutics, Inc · Industry
- Sex
- All
- Age
- 5 Years
- Healthy volunteers
- Not accepted
Summary
This is an observational prescreening study. Individuals who are eligible for prescreening will undergo testing procedures that may be used to determine eligibility in ACDN-01 clinical trials.
Detailed description
The prescreening process will be used to help determine the initial eligibility and interest of potential participants in ACDN-01 clinical trials by conducting assessments of key eligibility criteria before the clinical trial screening procedures are performed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Prescreening Assessments | Various genetic and visual assessments. |
Timeline
- Start date
- 2024-06-20
- Primary completion
- 2027-08-31
- Completion
- 2030-08-31
- First posted
- 2024-06-06
- Last updated
- 2026-03-11
Locations
8 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT06445322. Inclusion in this directory is not an endorsement.